A Study to Evaluate Impact of Ibrutinib on the Quality of Life (QOL) in Patients With Chronic Lymphocytic Leukemia
Clinical trial NCT04016636 · COMPLETED
Trial details
- NCT number
- NCT04016636
- Sponsor
- Mela Osorio Maria Jose
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2019-08-12
- Primary completion
- 2021-08-30
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.